DLTR
Dollar Tree, Inc
Featured
Zenas BioPharma, Inc. (ZBIO) Reports a Net Loss for Q4 FY25
Zenas BioPharma, Inc. (ZBIO) reported Q4 2025 GAAP loss of $1.39 per share, a wider loss than the -$1.19 estimate (16.8% wider).
14 hours ago
Dollar Tree, Inc. (DLTR) Beats Q4 Earnings Estimates
Dollar Tree, Inc. (DLTR) turned in Q4 2025 adjusted EPS of $2.56, exceeding the $2.20 Street estimate (beat by 16.4%).
Latest Transcripts
LiveMarket News
View All
U.S. Regulators Turn Up the Heat on Big Tech Acquisitions
For years, Silicon Valley relied on acquisitions as a core growth strategy. Large tech companies frequently bought startups to expand...
Costco’s Earnings Reignite the Consumer Resilience Debate
TL;DR: Costco’s latest earnings beat expectations, reinforcing the narrative that the U.S. consumer is still spending but the market is...
Airlines Face Margin Squeeze as Oil Spike Hits Fuel Costs
TL;DR: U.S. airlines abandoned fuel hedging years ago and with oil surging, that decision is suddenly coming back to haunt...